Leprosy
41
5
5
24
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.9%
2 terminated out of 41 trials
92.3%
+5.7% vs benchmark
15%
6 trials in Phase 3/4
17%
4 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 24 completed trials
Clinical Trials (41)
Prednisolone Monotherapy Versus Prednisolone Plus Methotrexate in ENL
Leprosy Active Searching Trial in Brazil
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
Potential Injection of Human Umbilical Cord Secretome in the Case of Trophic Ulcers (Pre-post Intervention)
Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers
Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025)
Integrating Mental Health Into Neglected Tropical Disease Care in Ghana
Novel Interventions and Diagnostic Tests for Leprosy
Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients
TGF β 1 Expression Related Gene Polymorphism
Serum Irisin Level In Leprosy Patients
Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia
The Effect of "Jinchuang Ointment" (JCO) on the Treatment of Wounds in Patients With Hansen's Disease.
The Effects of Traditional Chinese Medicine Mouthwash Solutions on the Oral Health of Leprosy Patients
Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients
Treatment of Neuropathic Pain in Leprosy